Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $39.9000 (-3.95%) ($39.6700 - $39.9000) on Fri. Apr. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.09% (three month average) | RSI | 43 | Latest Price | $39.9000(-3.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.7% a day on average for past five trading days. | Weekly Trend | HALO advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWM(44%) IWO(44%) IWN(42%) IWC(41%) | Factors Impacting HALO price | HALO will decline at least -1.045% in a week (0% probabilities). VIXM(-23%) UUP(-11%) VXX(-8%) TBT(-4%) GLD(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.045% (StdDev 2.09%) | Hourly BBV | -2.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $42.18 | 5 Day Moving Average | $42.2(-5.45%) | 10 Day Moving Average | $42.54(-6.21%) | 20 Day Moving Average | $42.18(-5.41%) | To recent high | -10.4% | To recent low | 21.8% | Market Cap | $5.453b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |